Co-administration of ibuprofen and nitric oxide is an effective experimental therapy for muscular dystrophy, with immediate applicability to humans

Protection of dystrophic muscle cells with polyphenols from green tea correlates with improved glutathione balance and increased expression of 67LR, a receptor for (−)-epigallocatechin gallate

(2009) Olivier M. Dorchies et al.   BIOFACTORS

Imatinib attenuates skeletal muscle dystrophy in mdx mice

(2009) Ping Huang et al.   FASEB JOURNAL

Loss of positive allosteric interactions between neuronal nitric oxide synthase and phosphofructokinase contributes to defects in glycolysis and increased fatigability in muscular dystrophy

(2009) M. Wehling-Henricks et al.   HUMAN MOLECULAR GENETICS

Multiple pathological events in exercised dystrophic mdx mice are targeted by pentoxifylline: outcome of a large array of in vivo and ex vivo tests

(2009) Rosa Burdi et al.   JOURNAL OF APPLIED PHYSIOLOGY

Dystrophins carrying spectrin-like repeats 16 and 17 anchor nNOS to the sarcolemma and enhance exercise performance in a mouse model of muscular dystrophy

(2009) Yi Lai et al.   JOURNAL OF CLINICAL INVESTIGATION

Diagnosis and new treatments in muscular dystrophies

(2009) A Y Manzur et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Nitric oxide generated by muscle corrects defects in hippocampal neurogenesis and neural differentiation caused by muscular dystrophy

(2009) Bo Deng et al.   JOURNAL OF PHYSIOLOGY-LONDON

Development of a Nitric Oxide-Releasing Analogue of the Muscle Relaxant Guaifenesin for Skeletal Muscle Satellite Cell Myogenesis

(2009) Guqi Wang et al.   MOLECULAR PHARMACEUTICS

MALDI reveals membrane lipid profile reversion in MDX mice

(2009) Farida Benabdellah et al.   NEUROBIOLOGY OF DISEASE

Nitric oxide and repair of skeletal muscle injury

(2009) Lidiane Isabel Filippin et al.   NITRIC OXIDE-BIOLOGY AND CHEMISTRY

l-Arginine Decreases Inflammation and Modulates the Nuclear Factor-κB/Matrix Metalloproteinase Cascade in Mdx Muscle Fibers

(2008) Karim Hnia et al.   AMERICAN JOURNAL OF PATHOLOGY

Investigation of Debio 025, a cyclophilin inhibitor, in the dystrophic mdx mouse, a model for Duchenne muscular dystrophy

(2008) J Reutenauer et al.   BRITISH JOURNAL OF PHARMACOLOGY

Sarcolemma-localized nNOS is required to maintain activity after mild exercise

(2008) Yvonne M. Kobayashi et al.   NATURE

Reduced muscle necrosis and long-term benefits in dystrophic mdx mice after cV1q (blockade of TNF) treatment

(2008) Hannah G. Radley et al.   NEUROMUSCULAR DISORDERS

Approaching a new age in Duchenne muscular dystrophy treatment

(2008) Kathryn R. Wagner   Neurotherapeutics

Functional Deficits in nNOSμ-Deficient Skeletal Muscle: Myopathy in nNOS Knockout Mice

(2008) Justin M. Percival et al.   PLoS One

HDAC2 blockade by nitric oxide and histone deacetylase inhibitors reveals a common target in Duchenne muscular dystrophy treatment

(2008) C. Colussi et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Nitric oxide reverses prednisolone-induced inactivation of muscle satellite cells

(2007) Jenna L. Betters et al.   MUSCLE & NERVE